MCO-010, an optogenetic therapy, demonstrated long-term safety and improved quality of life in patients with retinitis pigmentosa after a single intravitreal injection, according to a press release from Nanoscope Therapeutics.“Patients with RP suffer f…
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Esther M. Bowie, MD, discusses real-world data from the IRIS Registry on aflibercept 8 mg in wet age-related macular degeneration.Bowie, professor in the department of ophthalm…
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced that the Com…
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced that the Com…
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious med…
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Esther M. Bowie, MD, discusses results from the AVONELLE-X trial, the PULSAR trial and the Portal study in wet age-related macular degeneration.In AVONELLE-X, patients with wet…